RNAC Operating Income Growth
Cartesian Therapeutics Inc · Operating Income Growth
RNAC Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-12.10%period ending
RNAC TTM Operating Income YoY % (-37.01% → -12.10%)
Year-over-year change
High-resolution chart · PNG
RNAC operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -12.1049% | |
| -74.139% | |
| -97.5192% | |
| -71.0288% | |
| -79.6481% | |
| 35.5664% | |
| 49.2027% | |
| 8.6753% | |
| -3.9776% | |
| -456.8076% | |
| -694.4146% | |
| -316.0667% | |
| -276.1798% | |
| -209.6145% | |
| 416.2497% | |
| 263.5914% | |
| 194.368% | |
| 129.5281% | |
| 91.9097% | |
| 73.049% | |
| 52.4155% | |
| 24.005% | |
| -8.3233% | |
| -13.0719% | |
| -1.7461% | |
| 2.6922% | |
| 19.3273% | |
| 22.086% | |
| 13.5602% | |
| 5.7857% | |
| -1.9409% | |
| -19.5881% | |
| -30.2649% | |
| -52.4664% | |
| -83.9746% | |
| -109.0733% | |
| -96.0068% | |
| -60.8133% | |
| -37.0139% |